These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10080908)

  • 1. Analysis of the modulation of transcriptional activity in myelopoiesis and leukemogenesis.
    Behre G; Zhang P; Zhang DE; Tenen DG
    Methods; 1999 Mar; 17(3):231-7. PubMed ID: 10080908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.
    Ibañez V; Sharma A; Buonamici S; Verma A; Kalakonda S; Wang J; Kadkol S; Saunthararajah Y
    Cancer Res; 2004 Jul; 64(13):4547-54. PubMed ID: 15231665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domains involved in ETO and human N-CoR interaction and ETO transcription repression.
    Wang J; Wang M; Liu JM
    Leuk Res; 2004 Apr; 28(4):409-14. PubMed ID: 15109542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY; Christopeit M; Chen Y; Geletu M; Behre G
    Exp Hematol; 2008 Nov; 36(11):1449-60. PubMed ID: 18687517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.
    Wang J; Saunthararajah Y; Redner RL; Liu JM
    Cancer Res; 1999 Jun; 59(12):2766-9. PubMed ID: 10383127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
    J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.
    Racanicchi S; Maccherani C; Liberatore C; Billi M; Gelmetti V; Panigada M; Rizzo G; Nervi C; Grignani F
    EMBO J; 2005 Mar; 24(6):1232-42. PubMed ID: 15729358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of granulocyte and monocyte development.
    Friedman AD
    Oncogene; 2002 May; 21(21):3377-90. PubMed ID: 12032776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO.
    Lausen J; Liu S; Fliegauf M; Lübbert M; Werner MH
    Oncogene; 2006 Mar; 25(9):1349-57. PubMed ID: 16247445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.
    Kohzaki H; Ito K; Huang G; Wee HJ; Murakami Y; Ito Y
    Oncogene; 1999 Jul; 18(28):4055-62. PubMed ID: 10435586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
    Ferrara FF; Fazi F; Bianchini A; Padula F; Gelmetti V; Minucci S; Mancini M; Pelicci PG; Lo Coco F; Nervi C
    Cancer Res; 2001 Jan; 61(1):2-7. PubMed ID: 11196162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional control of granulocyte and monocyte development.
    Friedman AD
    Oncogene; 2007 Oct; 26(47):6816-28. PubMed ID: 17934488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor and leukemogenesis.
    de Figueiredo LL; de Abreu e Lima RS; Rego EM
    Mediators Inflamm; 2004 Jun; 13(3):145-50. PubMed ID: 15223604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.
    Fazi F; Racanicchi S; Zardo G; Starnes LM; Mancini M; Travaglini L; Diverio D; Ammatuna E; Cimino G; Lo-Coco F; Grignani F; Nervi C
    Cancer Cell; 2007 Nov; 12(5):457-66. PubMed ID: 17996649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THOC5 couples M-CSF receptor signaling to transcription factor expression.
    Carney L; Pierce A; Rijnen M; Gonzalez Sanchez MB; Hamzah HG; Zhang L; Tamura T; Whetton AD
    Cell Signal; 2009 Feb; 21(2):309-16. PubMed ID: 19015024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
    Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
    Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation.
    Rossetti S; Van Unen L; Touw IP; Hoogeveen AT; Sacchi N
    Oncogene; 2005 Aug; 24(34):5325-32. PubMed ID: 16007222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.